Artificial Intelligence start-up set to change UK healthcare market
Viz.ai, the artificial intelligence tech start-up, has announced the CE Mark of its Direct-to-Intervention system.
It is also due to launch its first trials in UK hospitals this year.
Viz.ai uses artificial intelligence and medical imaging software to improve patients’ experience between incident and treatment, known as the care pathway, which is often indirect and inefficient. Viz.ai offers a platform to expedite this assessment and treatment process.
Focused on stroke care initially, Viz.ai uses deep learning algorithms to identify suspected large vessel occlusions (a major form of stroke) and then notifies a specialist as soon as possible. Through providing the right information to the right doctor at the right time, the referral process can be reduced from hours to minutes.
NHS Consultant Surgeon and Viz.ai co-founder, Manoj Ramachandran comments: “Viz.ai heralds a fascinating shift in healthcare that sees the sector increase in efficiency as it embraces artificial intelligence.
“In stroke care, every minute matters, so it makes complete sense to utilise technology that allows us to treat patients faster. Viz.ai has incredible potential to save countless lives and greatly decrease costs to the strained health system.”
The news about Viz.ai follows recent comments by Norman Lamb, the chairman of the Commons Science and Technology Committee, who said the rewards of introducing AI to the NHS could be immense in terms of cost savings and diagnosing patients more quickly.
Stroke is a leading cause of death and disability in the UK. Each year, 100,000 people in the UK suffer from stroke, costing the NHS £3billion in related costs.